RLMD vs UPS · $692.3M cap vs P/E 15, rev $88.66B
Relmada Therapeutics Inc (RLMD) versus United Parcel Service Inc (UPS) — a side-by-side from cached financials, not a winner call.
Relmada Therapeutics Inc (RLMD) is a biotechnology company listed on NASDAQ.
United Parcel Service Inc (UPS) is a integrated freight & logistics company listed on US.
RLMD does not have a complete income-statement cache yet.
Latest reported UPS revenue for 2025-12-31 was $88.66B. Net income was $5.57B. Revenue was down 2.6% from 2024-12-31 to 2025-12-31. UPS currently screens at market cap $85.76B and trailing P/E 14.8.
RLMD currently screens at market cap $692.3M. UPS currently screens at market cap $85.76B and trailing P/E 14.8.
Not investment advice. Open the RLMD and UPS stock pages for the full models.
Not investment advice.